跳至主要内容
临床试验/NCT00449085
NCT00449085撤回2 期

Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

Biosense Webster, Inc.0 个研究点开始时间: 2007年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回

研究概览

简要总结

Feasibility study to evaluate CARTO™ XP EP Navigation System V9 and SOUNDSTAR 3D Diagnostic Ultrasound Catheter.

详细描述

To construct geometric representation of the heart chambers using intracardiac ultrasound.The Carto™ XP Electrophysiology (EP) Navigation System v9 is intended to acquire real-time catheter based cardiac electrophysiogical maps.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects undergoing any EPS study and or Ablation will be eligible for this study.
  • Age 18 years or older Signed Patient Informed Consent Form

排除标准

  • Patients with inadequate vascular access
  • Patients with any of the following criteria will be excluded:
  • Women who are pregnant
  • Age <18 years
  • Any Contraindication to the clinical procedure
  • Major coagulation abnormalities
  • Presence of any intracardiac thrombus
  • Unstable angina
  • Uncontrolled Heart failure
  • Deep Vein Thrombosis
  • Significant peripheral vascular disease

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Clinical Evaluation of the CARTO™ XP EP Navigation... | 临床试验